ImmunoPrecise’s B-Cell Select antibody discovery platform uses innovative technology that allows for antibody screening from any species of animal, from any tissue sample, to allow for earlier hit identification compared to traditional technologies.
The B-Cell Select Advantage
- Greater diversity of animal repertoires
- Applicable to any protein class, complex therapeutics targets, GPCRs and ion channels
- Maintains native heavy and light chain pairings
- Rapid immunization methods available
- Visualization of sequence diversity
- Applicable to transgenics and wild type animals